Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Posttransfusion hepatitis presents diagnostic challenges, particularly non-A, non-B types.
• Serological markers are crucial for identifying viral hepatitis infections.

Purpose of the Study:

• To investigate the serological evidence of hepatitis C virus (HCV) infection in patients with non-A, non-B posttransfusion hepatitis.
• To correlate antibody seroconversion to specific HCV antigens with disease severity and chronicity.

Main Methods:

• Analysis of stored sera from 40 patients with non-A, non-B posttransfusion hepatitis.
• Detection of antibodies against HCV antigens (C-100, 5-1-1, C-22, C-33) using specific assays.
• Correlation of serological findings with clinical data, including disease severity, chronicity, and patient demographics.

Main Results:

• Twenty-eight patients showed seroconversion ('documented hepatitis C') and experienced more severe initial disease, with all 20 chronic hepatitis cases occurring in this group.
• Patients developing antibodies to C-100 were younger and received more blood transfusions compared to those with antibodies to other antigens.
• The incidence of posttransfusion hepatitis associated with antibody seroconversion declined following the adoption of an all-volunteer blood system.

Conclusions:

• Hepatitis C virus seroconversion is a strong indicator of severe and chronic posttransfusion hepatitis.
• Antibody response to specific HCV antigens may correlate with patient characteristics and transfusion history.
• Clinical significance of hepatitis in patients without serological evidence of HCV exposure is often minimal and etiology may be non-viral.